Shuangchun Yan1, Amy Tsurumi, Yok-Ai Que, Colleen M Ryan, Arunava Bandyopadhaya, Alexander A Morgan, Patrick J Flaherty, Ronald G Tompkins, Laurence G Rahme. 1. *Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA †Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA ‡Shriners Hospitals for Children Boston, Boston, MA §Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland ¶Department of Biochemistry and Stanford Genome Technology Center, Stanford University School of Medicine, Palo Alto, CA ‖Department of Biomedical Engineering, Worcester Polytechnic Institute, Worchester, MA **Program in Bioinformatics and Computational Biology, Worcester Polytechnic Institute, Worchester, MA.
Abstract
OBJECTIVE: To develop predictive models for early triage of burn patients based on hypersusceptibility to repeated infections. BACKGROUND: Infection remains a major cause of mortality and morbidity after severe trauma, demanding new strategies to combat infections. Models for infection prediction are lacking. METHODS: Secondary analysis of 459 burn patients (≥16 years old) with 20% or more total body surface area burns recruited from 6 US burn centers. We compared blood transcriptomes with a 180-hour cutoff on the injury-to-transcriptome interval of 47 patients (≤1 infection episode) to those of 66 hypersusceptible patients [multiple (≥2) infection episodes (MIE)]. We used LASSO regression to select biomarkers and multivariate logistic regression to built models, accuracy of which were assessed by area under receiver operating characteristic curve (AUROC) and cross-validation. RESULTS: Three predictive models were developed using covariates of (1) clinical characteristics; (2) expression profiles of 14 genomic probes; (3) combining (1) and (2). The genomic and clinical models were highly predictive of MIE status [AUROCGenomic = 0.946 (95% CI: 0.906-0.986); AUROCClinical = 0.864 (CI: 0.794-0.933); AUROCGenomic/AUROCClinical P = 0.044]. Combined model has an increased AUROCCombined of 0.967 (CI: 0.940-0.993) compared with the individual models (AUROCCombined/AUROCClinical P = 0.0069). Hypersusceptible patients show early alterations in immune-related signaling pathways, epigenetic modulation, and chromatin remodeling. CONCLUSIONS: Early triage of burn patients more susceptible to infections can be made using clinical characteristics and/or genomic signatures. Genomic signature suggests new insights into the pathophysiology of hypersusceptibility to infection may lead to novel potential therapeutic or prophylactic targets.
OBJECTIVE: To develop predictive models for early triage of burn patients based on hypersusceptibility to repeated infections. BACKGROUND:Infection remains a major cause of mortality and morbidity after severe trauma, demanding new strategies to combat infections. Models for infection prediction are lacking. METHODS: Secondary analysis of 459 burn patients (≥16 years old) with 20% or more total body surface area burns recruited from 6 US burn centers. We compared blood transcriptomes with a 180-hour cutoff on the injury-to-transcriptome interval of 47 patients (≤1 infection episode) to those of 66 hypersusceptible patients [multiple (≥2) infection episodes (MIE)]. We used LASSO regression to select biomarkers and multivariate logistic regression to built models, accuracy of which were assessed by area under receiver operating characteristic curve (AUROC) and cross-validation. RESULTS: Three predictive models were developed using covariates of (1) clinical characteristics; (2) expression profiles of 14 genomic probes; (3) combining (1) and (2). The genomic and clinical models were highly predictive of MIE status [AUROCGenomic = 0.946 (95% CI: 0.906-0.986); AUROCClinical = 0.864 (CI: 0.794-0.933); AUROCGenomic/AUROCClinical P = 0.044]. Combined model has an increased AUROCCombined of 0.967 (CI: 0.940-0.993) compared with the individual models (AUROCCombined/AUROCClinical P = 0.0069). Hypersusceptible patients show early alterations in immune-related signaling pathways, epigenetic modulation, and chromatin remodeling. CONCLUSIONS: Early triage of burn patients more susceptible to infections can be made using clinical characteristics and/or genomic signatures. Genomic signature suggests new insights into the pathophysiology of hypersusceptibility to infection may lead to novel potential therapeutic or prophylactic targets.
Authors: Angela M Ingraham; Wei Xiong; Mark R Hemmila; Shahid Shafi; Sandra Goble; Melanie L Neal; Avery B Nathens Journal: Ann Surg Date: 2010-08 Impact factor: 12.969
Authors: Yiorgos Apidianakis; Yok-Ai Que; Weihong Xu; George P Tegos; Piotr Zimniak; Michael R Hamblin; Ronald G Tompkins; Wenzhong Xiao; Laurence G Rahme Journal: FASEB J Date: 2011-10-28 Impact factor: 5.191
Authors: Robert Kraft; David N Herndon; Ahmed M Al-Mousawi; Felicia N Williams; Celeste C Finnerty; Marc G Jeschke Journal: Lancet Date: 2012-01-31 Impact factor: 79.321
Authors: Alex G Cuenca; Lori F Gentile; M Cecilia Lopez; Ricardo Ungaro; Huazhi Liu; Wenzhong Xiao; Junhee Seok; Michael N Mindrinos; Darwin Ang; Tezcan Ozrazgat Baslanti; Azra Bihorac; Philip A Efron; Joseph Cuschieri; H Shaw Warren; Ronald G Tompkins; Ronald V Maier; Henry V Baker; Lyle L Moldawer Journal: Crit Care Med Date: 2013-05 Impact factor: 7.598
Authors: Laurens Kruidenier; Chun-wa Chung; Zhongjun Cheng; John Liddle; KaHing Che; Gerard Joberty; Marcus Bantscheff; Chas Bountra; Angela Bridges; Hawa Diallo; Dirk Eberhard; Sue Hutchinson; Emma Jones; Roy Katso; Melanie Leveridge; Palwinder K Mander; Julie Mosley; Cesar Ramirez-Molina; Paul Rowland; Christopher J Schofield; Robert J Sheppard; Julia E Smith; Catherine Swales; Robert Tanner; Pamela Thomas; Anthony Tumber; Gerard Drewes; Udo Oppermann; Dinshaw J Patel; Kevin Lee; David M Wilson Journal: Nature Date: 2012-08-16 Impact factor: 49.962
Authors: Michele A Bertocci; Genna Bebko; Amanda Dwojak; Satish Iyengar; Cecile D Ladouceur; Jay C Fournier; Amelia Versace; Susan B Perlman; Jorge R C Almeida; Michael J Travis; Mary Kay Gill; Lisa Bonar; Claudiu Schirda; Vaibhav A Diwadkar; Jeffrey L Sunshine; Scott K Holland; Robert A Kowatch; Boris Birmaher; David Axelson; Sarah M Horwitz; Thomas Frazier; L Eugene Arnold; Mary A Fristad; Eric A Youngstrom; Robert L Findling; Mary L Phillips Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2017-05
Authors: P Voirol; Y-A Que; A Fournier; P Eggimann; O Pantet; J L Pagani; E Dupuis-Lozeron; A Pannatier; F Sadeghipour Journal: Antimicrob Agents Chemother Date: 2018-02-23 Impact factor: 5.191
Authors: M A Bertocci; G Bebko; A Versace; S Iyengar; L Bonar; E E Forbes; J R C Almeida; S B Perlman; C Schirda; M J Travis; M K Gill; V A Diwadkar; J L Sunshine; S K Holland; R A Kowatch; B Birmaher; D A Axelson; T W Frazier; L E Arnold; M A Fristad; E A Youngstrom; S M Horwitz; R L Findling; M L Phillips Journal: Psychol Med Date: 2016-12-21 Impact factor: 7.723
Authors: Cressida Mahung; Wesley H Stepp; Clayton Long; Madison Malfitano; Irmak Saklayici; Shannon M Wallet; Laura Y Zhou; Haibo Zhou; Bruce A Cairns; Robert Maile Journal: J Trauma Acute Care Surg Date: 2022-03-30 Impact factor: 3.697
Authors: M A Bertocci; G Bebko; A Versace; J C Fournier; S Iyengar; T Olino; L Bonar; J R C Almeida; S B Perlman; C Schirda; M J Travis; M K Gill; V A Diwadkar; E E Forbes; J L Sunshine; S K Holland; R A Kowatch; B Birmaher; D Axelson; S M Horwitz; T W Frazier; L E Arnold; M A Fristad; E A Youngstrom; R L Findling; M L Phillips Journal: Mol Psychiatry Date: 2016-02-23 Impact factor: 15.992